Public Australian compound-jurisdiction data

41 names.
328 source routes.

One downloadable source map connecting compound identity, evidence lane, state and territory context, ARTG product checks, local pharmacy or medicines verification, and the exact atlas section for every row.

A source-routing atlas, not a jurisdiction-by-jurisdiction legal verdict.Each row preserves the research, clinical-pipeline, or medicine identity and connects it to national and local records. It does not certify a product, practitioner, seller, shipment, prescription, compounding basis, import route, medical use, or availability.
What this dataset adds

Compound identity joined to national and local records.

Every row retains the query, bounded answer, primary identity source, ARTG route, state or territory route, review date, and permanent atlas section.

01

Eight jurisdiction routes

The dataset covers every Australian state and territory, from New South Wales and Victoria to Tasmania, the ACT, and the Northern Territory.

02

41 identities

Research listings, investigational programs, and medicine records stay in separate evidence lanes even when search results combine them.

03

Every row is auditable

Open the human-readable atlas section, follow the official sources, or download the complete release for analysis and citation.

Human-readable jurisdiction maps

Open any of the 41 compound atlases.

Each atlas contains eight substantive jurisdiction answers, official local routes, ARTG links, regional guide handoffs, and the common identity source.

08US research-market identity with a separate FDA-licensed medicine record

Tesamorelin across Australia

Compare Tesamorelin across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

09US research-market identity with a failed oral obesity program and no FDA-approved drug

AOD-9604 across Australia

Compare AOD-9604 across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

12US research-market identity with a separate FDA-approved medicine record

PT-141 / Bremelanotide across Australia

Compare PT-141 / Bremelanotide across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

16China-approved medicine and active clinical program

Mazdutide across Australia

Compare Mazdutide across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

17China-approved medicine and active development program

Ecnoglutide across Australia

Compare Ecnoglutide across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

27Investigational clinical program

Amycretin / Zenagamtide across Australia

Compare Amycretin / Zenagamtide across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

29FDA-approved US medicine with country-specific status elsewhere

Orforglipron / Foundayo across Australia

Compare Orforglipron / Foundayo across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

30Product-specific approved medicine records in multiple jurisdictions

Semaglutide across Australia

Compare Semaglutide across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

31FDA-flagged unapproved research-market peptide identity

DSIP / Emideltide across Australia

Compare DSIP / Emideltide across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

33US research-market identity

Kisspeptin-10 / KP-10 across Australia

Compare Kisspeptin-10 / KP-10 across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

34US research-market identity separated from SCENESSE

Melanotan I across Australia

Compare Melanotan I across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

36US research-market identity with a withdrawn historical medicine record

Sermorelin across Australia

Compare Sermorelin across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

37No FDA-approved US product; exact foreign prescription products exist

Thymosin Alpha-1 across Australia

Compare Thymosin Alpha-1 across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

38FDA-approved US medicine with a withdrawn EU application

EGRIFTA WR across Australia

Compare EGRIFTA WR across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

39Product-specific FDA and EU medicine records

Liraglutide across Australia

Compare Liraglutide across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

40Product-specific FDA and EU medicine records

SCENESSE across Australia

Compare SCENESSE across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

41Product-specific FDA-approved US medicine record

VYLEESI across Australia

Compare VYLEESI across Australia's eight states and territories using official pharmacy, medicines, ARTG, and practitioner routes.

Data dictionary

Definitions travel with the download.

The dictionary keeps identity, ARTG checks, jurisdiction verification, and the publication boundary explicit.

FieldDefinition
recordIdStable Peptide Local identifier for one compound and Australian state or territory verification row.
compoundResolved research-market, clinical-pipeline, or medicine identity used by the linked evidence record.
evidenceLaneThe evidence category for the resolved identity. Research listings, clinical programs, and medicine records are not interchangeable.
jurisdictionDestination Australian state or territory whose official pharmacy, premises, or medicines route is linked.
searchQueryPlain-language compound and jurisdiction query represented by this row.
boundedAnswerEditorial routing answer stating what the identity, ARTG record, practitioner record, and local route can and cannot establish.
identitySourceUrlPrimary source for the compound, medicine, or clinical-program identity.
jurisdictionRecordUrlOfficial state or territory pharmacy, premises, medicines, licence, or registration route.
productRecordUrlTGA route used for the separate Australian Register of Therapeutic Goods check.
canonicalAtlasUrlCanonical Peptide Local atlas section for the exact compound and jurisdiction row.
reviewedDateISO date when the compound and Australian jurisdiction source route was reviewed.
Use and citation

Link the dataset page or exact atlas section.

Cite this landing page for the full release. For one compound and jurisdiction, cite the canonical atlas section so the bounded answer and source routes remain visible.

Corrections update the HTML atlas, CSV, and JSON from the same records. A row does not establish that a substance is legal, illegal, approved, unapproved, safe, unsafe, available, or suitable for an individual.

Compare the global 42-country dataset Open the Australia country guide Submit a correction